Clinical Trials in Denver

Showing 8501-8520 of 18,161 trials

Sorafenib Tosylate and Everolimus in Treating Patients With Advanced Solid Tumors and Metastatic Pancreatic Cancer That Does Not Respond to Gemcitabine Hydrochloride

NCT00981162

This phase I/II trial is studying the side effects and best dose of everolimus when given together with sorafenib tosylate and to see how well they work in treating patients with advanced solid tumors and metastatic pancreatic cancer that does not respond to gemcitabine hydrochloride. Sorafenib tosylate and everolimus may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Sorafenib tosylate may also stop the growth of pancreatic cancer by blocking blood flow to the tumor. Giving sorafenib tosylate together with everolimus may kill more tumor cells.

Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic Cancer+2 more

Roswell Park Cancer Institute12 participantsStarted Aug 2009

Aurora, Colorado, United States • Buffalo, New York, United States

TERMINATEDPhase 28.4 miles

Lovastatin for the Treatment of Mildly Active Rheumatoid Arthritis

NCT00302952

Rheumatoid arthritis (RA) is the most common inflammatory arthritis and a major health problem. The purpose of this study is to determine the safety and effectiveness of lovastatin for controlling inflammation in mildly active RA.

Rheumatoid Arthritis

National Institute of Allergy and Infectious Diseases (NIAID)64 participantsStarted Nov 2007

Birmingham, Alabama, United States • San Francisco, California, United States • Aurora, Colorado, United States +12 more locations

Sorafenib Tosylate and Everolimus in Treating Patients With Advanced Solid Tumors and Metastatic Pancreatic Cancer That Does Not Respond to Gemcitabine Hydrochloride

Lovastatin for the Treatment of Mildly Active Rheumatoid Arthritis

Find Trials by Condition in Denver

Neuronal and Behavioral Effects of Implicit Priming in Obese Individuals

Treatment of Metastatic Cancer in Terminally Diagnosed Patients

Safety, Tolerability, and Efficacy of AXA1125 in NASH With Fibrosis

An Exploratory, Open-Label, Oligo-Center Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Intravenous DNV3837 in Subjects With Clostridium Difficile Infection

Study to Assess if ABP798 is Safe & Effective in Treating Non Hodgkin Lymphoma Compared to Rituximab

A Comparison Study of LY2140023 and Aripiprazole in Schizophrenia Patients

Study to Evaluate the Safety and Efficacy of SDP-4 in Subjects With Dry Eye Disease (DED)

MR-Guided Focused Ultrasound in the Treatment of Focal Epilepsy (EP001)

A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis

The Safety, Efficacy and Pharmacokinetics of ARQ-151 Cream in Subjects With Chronic Plaque Psoriasis

Long-Term Safety of ARQ-151 Cream in Adult Subjects With Chronic Plaque Psoriasis

Feasibility Study for GORE® TAG® Thoracic Branch Endoprosthesis to Treat Proximal Descending Thoracic Aortic Aneurysms

Vopratelimab and a CTLA-4 Inhibitor in PD-1/PD-L1 Inhibitor Experienced Subjects With NSCLC or Urothelial Cancer

Mentors Offering Maternal Support (M-O-M-S™): A Prenatal Program for Decreasing Maternal Anxiety and Depression

A Study of LY2140023 in Schizophrenia Patients With Prominent Negative Symptoms

Safety and Efficacy Study of DUR-928 Topical Solution in Subjects With Plaque Psoriasis

A Treatment Use Protocol for Subjects Continuing on From the Open-label Extension 0601

Cinrebafusp Alfa in Combination With Ramucirumab and Paclitaxel in HER2-High Gastric or GEJ Adenocarcinoma and in Combination With Tucatinib in HER2-Low Gastric or GEJ Andenocarinoma